Related Experiment Video
Updated: Jul 6, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Anti-seizure Medications: Challenges and Opportunities
Neha Tandon1, Milica Radosavljevic1, Danijela Vucevic2
1Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
This review discusses anti-seizure medications (ASMs) for epilepsy, a neurological disorder causing recurrent seizures. It highlights newer ASMs offering better efficacy and safety across age groups, aiding physician treatment selection.
Area of Science:
- Neurology
- Pharmacology
Background:
- Epilepsy is a chronic neurological disorder defined by unprovoked, recurrent seizures.
- Causes of epilepsy are diverse, including genetic factors, brain injuries, and infections.
- Current epilepsy treatment primarily relies on anti-seizure medications (ASMs).
Purpose of the Study:
- To review the pharmacological characteristics, clinical applications, effectiveness, and safety of ASMs.
- To emphasize ASM therapy in different age groups, particularly children.
- To aid physicians in selecting appropriate ASMs for epilepsy management.
Main Methods:
- Review of pharmacological data and clinical trial outcomes for ASMs.
- Analysis of ASM efficacy and safety profiles across various patient demographics.
- Comparative assessment of older versus newer ASMs.
Main Results:
- Recent decades have seen advancements in ASMs, with new drugs offering broader mechanisms of action.
- Newer ASMs often present improved tolerability and reduced drug interactions.
- ASM selection is individualized based on seizure type, patient age, health, and potential interactions.
Conclusions:
- Comprehensive understanding of ASM therapy is crucial for effective epilepsy management.
- Physicians can optimize treatment by considering the specific characteristics of available ASMs.
- Ongoing research and development continue to improve therapeutic options for epilepsy patients.
More Related Videos
06:28Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
Published on: September 27, 2024
06:45Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
Related Concept Videos
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...